Evidence map›Paper›PMID 22483679›Full record

ArticleThe journal of pain2012

Analgesia targeting IB4-positive neurons in cancer-induced mechanical hypersensitivity.

Yi Ye, Dongmin Dang, Chi T Viet, John C Dolan, Brian L Schmidt

Open access · greenAbstract read
In one paragraph

Article in The journal of pain, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Tmem45b is essential for inflammation- and tissue injury-induced mechanical pain hypersensitivity.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Article
  5. Article
  6. Alleviating pain with delta opioid receptor agonists: evidence from experimental models.Journal of neural transmission (Vienna, Austria : 1996) · 2020
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Mediation of Movement-Induced Breakthrough Cancer Pain by IB4-Binding Nociceptors in Rats.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  12. Article
  13. Article
  14. The Neurobiology of Cancer Pain.Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons · 2015
    Review
  15. Article
  16. Article
  17. Article
  18. The neurobiology of cancer pain.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2014
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yi YeBluestone Center for Clinic Research, New York University, New York, NY, USA.
Dongmin Dang
Chi T Viet
John C Dolan
Brian L Schmidt
New York University · US

Funding

The Role of Proteases and Peptides in Cancer PainR01DE019796 · NIDCR · NEW YORK UNIVERSITY · PI HARDT, MARKUS, SCHMIDT, BRIAN L · 2010 to 2014
$2.8M
A Novel Gnawing Assay to Quantify Nociception in Models of Chronic Orofacial PainR21DE018561 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHMIDT, BRIAN L · 2007 to 2008
$422k
NIDCR NIH HHS R01 DE019796NIDCR NIH HHS R21DE01856NIDCR NIH HHS R21 DE018561
6 · The paper itself

Abstract

unlabelledCancer patients often suffer from pain and most will be prescribed μ-opioids. μ-opioids are not satisfactory in treating cancer pain and are associated with multiple debilitating side effects. Recent studies show that μ and δ opioid receptors are separately expressed on IB4 (-) and IB4 (+) neurons, which control thermal and mechanical pain, respectively. In this study we investigated IB4 (+) and IB4 (-) neurons in mechanical and thermal hypersensitivity in an orthotopic mouse oral cancer model. We used a δ opioid receptor agonist and a P2X(3) antagonist to target IB4 (+) neurons and to demonstrate that this subset plays a key role in cancer-induced mechanical allodynia, but not in thermal hyperalgesia. Moreover, selective removal of IB4 (+) neurons using IB4-saporin impacts cancer-induced mechanical but not thermal hypersensitivity. Our results demonstrate that peripherally administered pharmacological agents targeting IB4 (+) neurons, such as a selective δ-opioid receptor agonist or P2X(3) antagonist, might be useful in treating oral cancer pain. PERSPECTIVE: To clarify the mechanisms of oral cancer pain, we examined the differential role of IB4 (+) and IB4 (-) neurons. Characterization of these 2 subsets of putative nociceptors is important for further development of effective clinical cancer pain relief.

Indexed as

AnalgesicsAnimalsCarcinoma, Squamous CellCell Line, TumorDisease Models, AnimalHumansHyperalgesiaLectinsMaleMiceMice, Inbred C57BLMouth NeoplasmsNeoplasms, ExperimentalNeoplasm TransplantationNociceptionPainAnalgesicsLectinsReceptors, Opioid, mu

Identifiers

PMID22483679
PMCPMC3786360
OpenAlexW2057588372

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.